Company Filing History:
4 out of 8 
2 out of 4 
1 out of 204 
Years Active: 2020-2024
Title: The Innovative Contributions of Saravanan Karuppagounder
Introduction
Saravanan Karuppagounder is a notable inventor based in White Plains, NY (US). He has made significant contributions to the field of neuroscience and medicine, holding a total of five patents. His work primarily focuses on innovative methods for treating central nervous system disorders and conditions associated with selenium deficiency.
Latest Patents
One of his latest patents involves the use of N-acetylcysteine to treat central nervous system disorders. This patent describes methods for addressing conditions associated with oxidative stress using a 5-lipoxygenase activating protein (FLAP) inhibitor. The invention also outlines the combination of N-acetylcysteine with a second therapeutic agent, such as prostaglandin E2, to enhance treatment efficacy. Another significant patent relates to methods of administering compounds containing selenium, selenocysteine, or selenocysteine peptides. This invention aims to treat conditions associated with selenium deficiency, as well as ferroptotic, parthanototic, and endoplasmic reticulum stress, and cancer. The methods may involve the use of targeting sequences for specific organ delivery and various administration routes, including oral and intravenous methods.
Career Highlights
Throughout his career, Saravanan has worked with esteemed organizations such as the Burke Neurological Institute and Neuronasal, Inc. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects.
Collaborations
Saravanan has collaborated with notable colleagues, including Rajiv R Ratan and Thomas I Bradshaw. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Saravanan Karuppagounder is a distinguished inventor whose work has the potential to significantly impact the treatment of central nervous system disorders and related health issues. His innovative patents and collaborations highlight his commitment to advancing medical science.